These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3539128

  • 1. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K, Zahner G, Dietlein G, Franz I.
    Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
    [Abstract] [Full Text] [Related]

  • 2. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A.
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [Abstract] [Full Text] [Related]

  • 3. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z, Shupak A, Gordon CR.
    Clin Pharmacokinet; 2006 Sep; 45(6):543-66. PubMed ID: 16719539
    [Abstract] [Full Text] [Related]

  • 4. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S, Shapira S, Zilbiger A, Ribak J.
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [Abstract] [Full Text] [Related]

  • 5. Antimotion sickness and antiemetic drugs.
    Wood CD.
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract] [Full Text] [Related]

  • 6. [Comparison of transdermal scopolamine and dimenhydrinate in acute vestibular disease].
    Wolf M, Kronenberg J, Leventon G.
    Harefuah; 1987 Aug; 113(3-4):65-6. PubMed ID: 3500900
    [No Abstract] [Full Text] [Related]

  • 7. Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo.
    Klöcker N, Hanschke W, Toussaint S, Verse T.
    Eur J Pharm Sci; 2001 May; 13(2):227-32. PubMed ID: 11297908
    [Abstract] [Full Text] [Related]

  • 8. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME, Royal JW, Shaw JE, Schmitt LG.
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [Abstract] [Full Text] [Related]

  • 9. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I, Padoan S, Schalén L, Lyttkens L, Magnusson M, Henriksson NG.
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness.
    Pyykkö I, Schalén L, Jäntti V.
    Acta Otolaryngol; 1985 Aug; 99(5-6):588-96. PubMed ID: 4024909
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM, Schmitt LG, McGuire J, Shaw JE, Trobough G.
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD, Graybiel A.
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.